Pritesh Shah Insider Trading for March 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Pritesh Shah.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Pritesh Shah for March 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | A | 47.04 | 33,783 | 1,589,152 | 33,783 | |
| Mar 26 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Grant | A | 0.00 | 18,452 | 0 | 43,691 | 25.2 K to 43.7 K (+73.11 %) |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 21.15 | 16,897 | 357,372 | 45,961 | |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 7.15 | 16,250 | 116,188 | 18,514 | |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 11.46 | 7,439 | 85,251 | 24 | |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 56.09 | 7,736 | 433,943 | 25,239 | 33 K to 25.2 K (-23.46 %) |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 55.23 | 9,161 | 505,990 | 32,975 | 42.1 K to 33 K (-21.74 %) |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 21.15 | 16,897 | 357,372 | 42,136 | 25.2 K to 42.1 K (+66.95 %) |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 56.10 | 7,517 | 421,681 | 25,239 | 32.8 K to 25.2 K (-22.95 %) |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 55.23 | 8,733 | 482,297 | 32,756 | 41.5 K to 32.8 K (-21.05 %) |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 7.15 | 16,250 | 116,188 | 41,489 | 25.2 K to 41.5 K (+64.38 %) |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 56.11 | 3,312 | 185,840 | 25,239 | 28.6 K to 25.2 K (-11.60 %) |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 55.23 | 4,127 | 227,947 | 28,551 | 32.7 K to 28.6 K (-12.63 %) |
| Mar 04 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 11.46 | 7,439 | 85,251 | 32,678 | 25.2 K to 32.7 K (+29.47 %) |